BEAMSTART Logo

Philip Marshall

CEO of ORIL

About Philip Marshall

Over 30 years experience in senior executive roles in pharma & biotech companies;
Founder & Director of global specialist consultancy firm to pharma;
Authorised Australia Govt. GMP Auditor;
Co-investor of ORIL’s chemistry patents


Work & Companies

Oncology Research International Ltd

Australia

ORIL is a public-unlisted biotech start-up headquartered in Adelaide, Australia; Founded by a cancer survivor, it has been carrying on the research work in low-cost & effective treatment of cancer based on chemical compounds found in natural recurring substance, using traditional Chinese medicine (TCM) approach; Currently the Company’s new chemical entity ORIL19 has been approved strong efficacy in curing liver & breasts cancer during pre-clinical research; the Company has been strongly encouraged & approved by US FDA to conduct clinical phase 1 research, but is in need of approx. AU$2-5m (US$1.5m) for funding the regulatory filing costs & ongoing research expenses


Education & Qualifications

No qualifications added yet.

Philip Marshall has not been added any qualifications yet.


Articles, Links, and Press

No articles or coverage yet.

Have a news story to share? Tell us about it.

BEAMSTART is a hub for everything Startups, Entrepreneurship, and Innovation. Connect with a global community of people, and stay updated with the latest news, events, and opportunities.

 

Download the Community App

Connect with the BEAMSTART Entrepreneurship Community from the palm of your hands. Connect with CEOs/Founders, Investors, Business Leaders, and Professionals. Download below to instantly form partnerships and discover opportunities:

PlayStore ButtonAppStore Button

© 2016 - 2021 BEAMSTART. All Rights Reserved (Legal).